Christopher Veremakis, MD

Medical Director, Center for Innovative Care
Mercy Virtual - Mercy Health

In 2006, when Mercy began its first telehealth initiative, Dr. Chris Veremakis became medical director of Mercy SafeWatch, the largest single-hub remote electronic ICU in the country. This tele-ICU monitors over 450 + ICU beds in Missouri, Oklahoma, Kansas , Arkansas and South Carolina . In 2010, he provided medical leadership for the Mercy telestroke/ teleneurology program which has grown to presently cover 28 hospitals across a four state region. He subsequently gave up his 25 year bedside critical care practice to become medical director of Telehealth Services for Mercy’s new business unit, Mercy Virtual . Previously, Dr. Veremakis was chair of Critical Care Medicine at Mercy Hospital St. Louis, a 980-bed independent teaching hospital and Level I trauma center in suburban St. Louis, Mo., from 1984-2009. During that time, he built a Critical Care Medicine department that currently numbers 18 full-time intensivists who assume primary management of adult medical and surgical ICU patients in over 80 ICU and step-down beds.

A lifelong physician educator, Dr. Veremakis is a clinical professor of medicine at Saint Louis University and served as program director for the Saint Louis University/Mercy Hospital St. Louis Critical Care Subspecialty Residency from 1985-1994. From 1994-2000, he was a member of the ABIM CCM certification test committee, and in 2006 began a six year term on the ACGME’s institutional review committee. He is also an active member of the board of directors of Mid America Transplant Services.

Dr. Veremakis graduated from Saint Louis University School of Medicine in St. Louis, Mo. in 1975. He completed his residency in Internal Medicine at Mercy Hospital St. Louis and completed his subspecialty residency in Critical Care Medicine at the University of Pittsburgh in 1980. He achieved board certification in Internal Medicine (1979), Critical Care Medicine (1987) and Neurocritical Care Medicine (2011).